GREGORI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 6.549
AS - Asia 3.028
EU - Europa 3.006
SA - Sud America 447
AF - Africa 83
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.129
Nazione #
US - Stati Uniti d'America 6.196
SG - Singapore 1.005
CN - Cina 777
IT - Italia 590
DE - Germania 496
HK - Hong Kong 358
RU - Federazione Russa 352
SE - Svezia 321
BR - Brasile 319
CA - Canada 317
VN - Vietnam 305
IE - Irlanda 255
GB - Regno Unito 204
UA - Ucraina 188
IN - India 159
FR - Francia 149
PL - Polonia 94
FI - Finlandia 86
AT - Austria 65
BD - Bangladesh 55
DK - Danimarca 50
TR - Turchia 50
KR - Corea 43
AR - Argentina 41
ZA - Sudafrica 40
IR - Iran 39
IQ - Iraq 38
NL - Olanda 34
JP - Giappone 33
BE - Belgio 30
ID - Indonesia 23
ES - Italia 22
VE - Venezuela 21
MX - Messico 19
PK - Pakistan 17
EC - Ecuador 16
SA - Arabia Saudita 15
UZ - Uzbekistan 13
CO - Colombia 12
MY - Malesia 11
PH - Filippine 11
CL - Cile 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
JO - Giordania 9
PT - Portogallo 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
UY - Uruguay 8
GR - Grecia 7
MA - Marocco 7
NP - Nepal 7
TW - Taiwan 7
AU - Australia 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
KE - Kenya 6
OM - Oman 6
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
CH - Svizzera 5
EU - Europa 5
HU - Ungheria 5
LT - Lituania 5
TH - Thailandia 5
BG - Bulgaria 4
PE - Perù 4
DO - Repubblica Dominicana 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
NZ - Nuova Zelanda 3
TN - Tunisia 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
GE - Georgia 2
HN - Honduras 2
LV - Lettonia 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
Totale 13.117
Città #
Ann Arbor 942
Singapore 607
Ashburn 594
Woodbridge 557
San Jose 342
Chandler 339
Hong Kong 333
Fairfield 328
Frankfurt am Main 279
Wilmington 258
Houston 250
Dublin 247
Milan 237
Jacksonville 208
Dearborn 194
Toronto 179
Beijing 140
Seattle 137
New York 126
Cambridge 121
Santa Clara 114
Los Angeles 92
Dallas 83
Princeton 82
Ho Chi Minh City 79
Kraków 69
Hanoi 68
Shanghai 68
Nanjing 67
Chicago 64
The Dalles 59
Vienna 59
Ottawa 48
Wayne 43
Lachine 39
Lauterbourg 39
Hefei 38
São Paulo 38
Council Bluffs 37
Helsinki 34
Moscow 34
Altamura 33
Buffalo 31
Guangzhou 30
Lawrence 30
Dong Ket 29
Brussels 28
Nanchang 28
Orem 28
Rome 27
Seoul 27
San Diego 26
Boardman 23
Munich 22
Tokyo 22
Tianjin 19
Brooklyn 18
Chennai 18
Fremont 18
London 18
Changsha 17
Hangzhou 17
Johannesburg 17
Baghdad 15
Jakarta 15
Shenyang 15
Warsaw 15
Pune 14
Montreal 13
Mumbai 13
Rio de Janeiro 13
Stockholm 13
Atlanta 12
Hebei 12
Kunming 12
Phoenix 12
Tashkent 12
Andover 11
Manchester 11
Quito 11
Zhengzhou 11
Amsterdam 10
Boston 10
Columbus 9
Edmonton 9
Grafing 9
Jiaxing 9
Jinan 9
Montréal 9
Turku 9
Brno 8
Copenhagen 8
Da Nang 8
Jeddah 8
Lahore 8
Nuremberg 8
Salt Lake City 8
Belo Horizonte 7
Cape Town 7
Caracas 7
Totale 8.588
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 731
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 486
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 472
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 460
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 451
Morphogenic effect of common solvent in the self-assembly behavior of amphiphilic PEO-b-PLA 435
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 433
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 422
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 407
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 392
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 374
Curcumin derivatives as new ligands of Aβ peptides 346
Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compounds 344
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 339
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 337
Combinatorial Approaches to Iminosugars as Glycosidase and Glycosyltransferase Inhibitors 318
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 312
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: The chemical design affects the permeability across an in vitro model 309
Synthesis and biological evaluation of a small library of nojirimycin derived bicyclic iminosugars 306
Fructose-based proline analogues: Exploring the prolyl trans/cis-amide rotamer population in model peptides 295
Synthesis and characterization of a paramagnetic sialic acid conjugate as probe for magnetic resonance applications 282
mApoE-Functionalized Nanoliposomes Delivering Doxorubicin and Ultrasmall Superparamagnetic Iron Oxide to Glioblastoma Cells Characterized by TEM and Confocal Microscopy 281
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 274
Functionalization with curcumin-derivative and TAT peptide enhances the interaction with human brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 270
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 267
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide 266
A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease 263
A membrane-bound trehalase from Chironomus riparius larvae: Purification and sensitivity to inhibition 261
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 261
Nanomedicine for the treatment of Alzheimer's disease 259
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model 259
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 254
Nanotechnology for neurodegenerative disorders 247
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 244
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 242
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response 238
Stability of Aβ (1-42) peptide fibrils as consequence of environmental modifications 237
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 233
Glycans in Magnetic Resonance Imaging: Determinants of Relaxivity to Smart Agents, and Potential Applications in Biomedicine 232
Nanotechnology for neurodegenerative disorders 217
Liposomes functionalized with GT1b ganglioside with high affinity for amyloid beta-peptide 207
Design of nanoparticles for the treatment of brain tumors 195
Totale 13.458
Categoria #
all - tutte 38.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.601


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022689 50 84 66 65 22 41 65 49 26 59 62 100
2022/20231.250 133 352 141 134 70 184 18 76 84 10 29 19
2023/2024803 17 35 49 51 108 197 166 38 50 10 10 72
2024/20251.659 94 186 123 62 138 62 106 57 169 261 146 255
2025/20264.167 487 193 354 430 544 216 624 173 312 396 239 199
2026/20273 3 0 0 0 0 0 0 0 0 0 0 0
Totale 13.458